We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.29B
1-Year Est. Return 4.86%
This Fund
S&P 500
This Quarter Est. Return
+7.09%
1 Year Est. Return
-4.86%
3 Year Est. Return
+64.44%
5 Year Est. Return
+96.88%
10 Year Est. Return
+353.21%
AUM
$2.9B
AUM Growth
+$253M
Cap. Flow
+$79M
Cap. Flow %
2.72%
Top 10 Hldgs %
65.67%
Holding
271
New
5
Increased
165
Reduced
26
Closed
17

Top Buys

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$5.1M
2
KO icon
Coca-Cola
KO
+$5M
3
INTU icon
Intuit
INTU
+$4.9M
4
ADI icon
Analog Devices
ADI
+$4.77M
5
XLNX
Xilinx Inc
XLNX
+$4.31M

Top Sells

Rank Stock Value
1
CARG icon
CarGurus
CARG
+$10.6M
2
LLY icon
Eli Lilly
LLY
+$4.28M
3
BPMC
Blueprint Medicines
BPMC
+$3.79M
4
BMY icon
Bristol-Myers Squibb
BMY
+$2.68M
5
BSX icon
Boston Scientific
BSX
+$2.51M

Sector Composition

Rank Sector Weight
1 Healthcare 53.05%
2 Energy 7.71%
3 Communication Services 6.5%
4 Technology 5.85%
5 Utilities 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JWN
226
DELISTED
Nordstrom
JWN
$18K ﹤0.01%
554
+6
+1% +$226
NBR icon
227
Nabors Industries
NBR
$1.34B
$17K ﹤0.01%
116
-775
-87% -$124K
PLXS icon
228
Plexus
PLXS
$6.53B
$14K ﹤0.01%
240
– –
GAP
229
The Gap Inc
GAP
$7.21B
$14K ﹤0.01%
789
+8
+1% +$179
EFA icon
230
iShares MSCI EAFE ETF
EFA
$78.2B
$13K ﹤0.01%
203
+4
+2% +$262
BTI icon
231
British American Tobacco
BTI
$121B
$12K ﹤0.01%
338
-11,951
-97% -$453K
BUD icon
232
AB InBev
BUD
$158B
$11K ﹤0.01%
123
+1
+0.8% +$86
MCK icon
233
McKesson
MCK
$104B
$11K ﹤0.01%
83
– –
WMB icon
234
Williams Companies
WMB
$87.6B
$11K ﹤0.01%
390
+5
+1% +$139
SWAV
235
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$11K ﹤0.01%
200
– –
KDP icon
236
Keurig Dr Pepper
KDP
$43.4B
$10K ﹤0.01%
359
+2
+0.6% +$57
OIH icon
237
VanEck Oil Services ETF
OIH
$2B
$10K ﹤0.01%
33
– –
NVT icon
238
nVent Electric
NVT
$24.2B
$9K ﹤0.01%
382
– –
ASIX icon
239
AdvanSix
ASIX
$447M
$8K ﹤0.01%
326
– –
TEF
240
DELISTED
Telefonica
TEF
$8K ﹤0.01%
1,235
– –
EWJ icon
241
iShares MSCI Japan ETF
EWJ
$23.6B
$7K ﹤0.01%
120
+1
+0.8% +$54
DELL icon
242
Dell
DELL
$361B
$6K ﹤0.01%
235
– –
ZBH icon
243
Zimmer Biomet
ZBH
$18.6B
$6K ﹤0.01%
50
– –
CNDT icon
244
Conduent
CNDT
$255M
$5K ﹤0.01%
530
– –
WAB icon
245
Wabtec
WAB
$47.2B
$4K ﹤0.01%
49
-87
-64% -$6.17K
HPQ icon
246
HP
HPQ
$30B
$3K ﹤0.01%
157
+1
+0.6% +$20
HPE icon
247
Hewlett Packard
HPE
$76.6B
$2K ﹤0.01%
151
+2
+1% +$30
DXC icon
248
DXC Technology
DXC
$1.87B
$1K ﹤0.01%
12
– –
ADNT icon
249
Adient
ADNT
$1.43B
– –
-1,411
Closed -$18K
BPMC
250
DELISTED
Blueprint Medicines
BPMC
– –
-47,300
Closed -$3.79M
7 8 9
10
11

Similar funds

VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OCM
Oribel Capital Management New York $3.29B AUM 83.82% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.3B AUM 0.25% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $3.3B AUM 16.21% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Bollard Group's Q2 2019 Portfolio in Review

As of Q2 2019, Bollard Group held 271 positions worth $2.9B, up 9.6% from $2.65B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bollard Group's Q2 2019 filing shows 5 new, 165 increased, 26 reduced and 17 closed positions. Its largest new stake was Intuit: 19,300 shares worth $5.04M. The largest sale was CarGurus, an estimated $10.6M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 53% a quarter earlier, followed by Energy and Communication Services.

  • Bollard Group's largest Q2 2019 buy was Intuit: 19,300 shares worth $5.04M.
  • Bollard Group added most to Kimberly-Clark in Q2 2019, an estimated $5.1M increase.
  • Bollard Group's biggest Q2 2019 reduction was CarGurus, cutting an estimated $10.6M.
  • Bollard Group fully exited Blueprint Medicines in Q2 2019, selling an estimated $3.79M.
  • Bollard Group's ten largest holdings make up 66% of its $2.9B portfolio in Q2 2019.
  • Bollard Group opened 5 new positions and closed 17 in Q2 2019.
  • Bollard Group's portfolio value rose 9.6% quarter-over-quarter to $2.9B.

Based on Bollard Group's 13F filing for Q2 2019, filed 13 Aug 2019.